prIME Oncology invites you to view a daily Webcast of interviews with Nordic Region Experts from the 45th ASCO Annual Meeting in Orlando, Florida.

Follow the links below to view the expert interviews conducted by Lee Lokey, MD discussing key abstracts presented on Saturday, May 30, 2009.

View Expert Interview with Professor Per E. Lønning, MD, PhD

View Expert Interview with Professor Hans Wadenvik, MD, PhD

This clinical update focuses on the following data releases:

Breast cancer (BC):

• Abstract #CRA508: Risk of BC recurrence in women initiating tamoxifen with CYP2D6 inhibitors
• Abstract #CRA509: Concomitant CYP2D6 inhibitor use and tamoxifen adherence in early-stage BC: A pharmacoepidemiologic study
  
• Abstract #510: Cognitive function in postmenopausal women receiving adjuvant letrozole or TAM in Breast International Group (BIG) 1-98
• Abstract #LBA515: Breast cancer molecular profiles predict tumor response of neoadjuvant doxorubicin and paclitaxel, the I-SPY TRIAL (CALGB 150007/150012, ACRIN 6657)
• Abstract #512: 70-gene profile and chemotherapy benefit in 1600 BC patients 

Hematologic malignancies:

• Abstract #7029: Nilotinib in CML patients in chronic phase with imatinib resistance or intolerance: longer follow-up results of a phase II study
• Abstract #7074: Molecular responses with nilotinib 800 mg daily as first-line treatment of CML in chronic phase